BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 24 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 24 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago
ADVERTISEMENT
Market News

Marvell Technology trips on weak guidance once again in Q3

Shares of Marvell Technology Group (NASDAQ: MRVL) declined during after-market hours on Tuesday, after the semiconductor firm reported a slight revenue miss in Q3, besides weaker-than-expected Q4 earnings outlook. Revenues for the third quarter declined 22% to $662 million, which fell shy of the street target of $664.5 million. Net income halved to 17 cents […]

December 3, 2019 2 min read

Shares of Marvell Technology Group (NASDAQ: MRVL) declined during after-market hours on Tuesday, after the semiconductor firm reported a slight revenue miss in Q3, besides weaker-than-expected Q4 earnings outlook.

Revenues for the third quarter declined 22% to $662 million, which fell shy of the street target of $664.5 million. Net income halved to 17 cents per share, which was in line with what the street had expected.  

Outlook

For the final quarter of the fiscal year, Marvell expects revenue of approximately $750 million. Adjusted net income for this period is predicted in the range of 15-19 cents, whereas analysts were expecting around 21 cents per share.

Marvell CEO Matt Murphy said the company ramped its first 5G
product shipments in volume, ahead of the plan laid out earlier this year.

“We also recently completed the strategic acquisitions of Aquantia, a pioneer in multi-gig ethernet, and Avera, a leader in custom ASICs. These acquisitions broaden our technology portfolio for infrastructure customers and expand our addressable market by approximately $4 billion,” he added.

ADVERTISEMENT

Coupa Software (COUP) Q3 earnings, revenue beat; provides FY20 outlook

MRVL stock fell 1.5% immediately following the announcement. It has been a pretty good year so far for the semiconductor firm, with the stock gaining almost 51%.

Marvell is pinning its hopes on the ramp-up of 5G technology from its clients. However, 5G-related deployment benefits would be accretive to the top and bottom line either in the Q4 period or in the next fiscal year.

Get access to timely and accurate
verbatim transcripts that are published within hours of the event.

ADVERTISEMENT